Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$15,671,132
+$1,836,811 QoQ
Shares Held
62,276
-2.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.55%
of 13F equity value
Holder Rank
#721
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Palisade Asset Management, LLC holds $93,677,669 across 8 Drug Manufacturers - General names. ABBV ranks #4 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
72,776 | $26,353,645 | |
| 2 | JNJ |
Johnson & Johnson
|
100,872 | $25,618,461 | |
| 3 | LLY |
ELI LILLY & Co
|
14,193 | $17,023,511 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
62,276 | $15,671,132 | |
| 5 | MRK |
Merck & Co., Inc.
|
35,395 | $4,548,257 | |
| 6 | NVS |
Novartis AG
|
15,639 | $2,450,944 | |
| 7 | PFE |
Pfizer Inc
|
44,085 | $1,061,566 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,490 | $950,153 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,671,132 | 62,276 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $13,834,321 | 63,609 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $14,541,789 | 63,643 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,071,401 | 65,092 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $12,123,027 | 65,311 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $13,958,850 | 66,623 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $15,771,408 | 88,753 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $17,766,880 | 89,968 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $15,397,178 | 89,769 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $17,725,796 | 97,341 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $9,108,981 | 58,779 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $8,781,273 | 58,911 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $7,977,498 | 59,211 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $9,436,457 | 59,211 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $11,930,858 | 73,825 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $7,990,326 | 59,536 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $9,156,823 | 59,786 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $9,707,146 | 59,880 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $8,160,016 | 60,266 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $6,457,421 | 59,863 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $6,676,736 | 59,275 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $6,407,814 | 59,211 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $6,226,593 | 58,111 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $5,086,876 | 58,076 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $5,726,446 | 58,326 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $5,550,898 | 72,856 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||